Defence Therapeutics Stock Performance

Defence Therapeutics Relative Risk vs. Return Landscape

If you would invest  58.00  in Defence Therapeutics on November 16, 2025 and sell it today you would lose (11.00) from holding Defence Therapeutics or give up 18.97% of portfolio value over 90 days. Defence Therapeutics is currently producing negative expected returns and takes up 5.2878% volatility of returns over 90 trading days. Put another way, 47% of traded otc stocks are less volatile than Defence, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.Assuming the 90 days horizon Defence Therapeutics is expected to under-perform the market. In addition to that, the company is 6.87 times more volatile than its market benchmark. It trades about -0.04 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.13 per unit of volatility.

Defence Therapeutics Target Price Odds to finish over Current Price

Assuming the 90 days horizon Defence Therapeutics has a beta of 0.24 suggesting as returns on the market go up, Defence Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Defence Therapeutics will be expected to be much smaller as well. Additionally Defence Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.

Predictive Modules for Defence Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Defence Therapeutics. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.02 0.47 5.76 Details

Intrinsic Valuation Low Real High 0.02 0.42 5.71 Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Defence Therapeutics. Your research has to be compared to or analyzed against Defence Therapeutics' peers to derive any actionable benefits. When done correctly, Defence Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Defence Therapeutics.

Defence Therapeutics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Defence Therapeutics is not an exception. The market had few large corrections towards the Defence Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Defence Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Defence Therapeutics within the framework of very fundamental risk indicators.

Defence Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Defence Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Defence Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Defence Therapeutics Fundamentals Growth

When running Defence Therapeutics' price analysis, check to measure Defence Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Defence Therapeutics is operating at the current time. Most of Defence Therapeutics' value examination focuses on studying past and present price action to predict the probability of Defence Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Defence Therapeutics' price. Additionally, you may evaluate how the addition of Defence Therapeutics to your portfolios can decrease your overall portfolio volatility.